Modeling and Simulation Archives

Blog

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…

Certara2025 年 10 月 22 日

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

Certara2025 年 10 月 21 日

Video

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…

Certara2025 年 10 月 16 日

Video

Immuno-oncology (IO) Simulator in Certara IQ™

Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…

Certara2025 年 10 月 16 日

Video

ADC Modeling and Design with Certara IQ™

Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…

Certara2025 年 10 月 16 日

Video

Prebuilt Pharmacology Models in Certara IQ™

Certara IQ Pharmacology Models | Prebuilt Mechanistic Models for Faster QSP Research

Certara2025 年 10 月 16 日

Video

QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™

Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…

Certara2025 年 10 月 16 日

Video

Modeling Alzheimer’s Disease with Certara IQ™

Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…

Certara2025 年 10 月 16 日

Video

Early Feasibility Assessment (EFA) with Certara IQ™

Learn how Certara IQ performs early feasibility assessments (EFA) to predict biotherapeutic dosing, guide candidate…

Certara2025 年 10 月 16 日

Video

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

Learn how Certara IQ predicts recommended Phase 2 doses using advanced QSP modeling workflows that…

Certara2025 年 10 月 16 日

建模与模拟

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Immuno-oncology (IO) Simulator in Certara IQ™

ADC Modeling and Design with Certara IQ™

Prebuilt Pharmacology Models in Certara IQ™

QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™

Modeling Alzheimer’s Disease with Certara IQ™

Early Feasibility Assessment (EFA) with Certara IQ™

Certara IQ™: Predicting Recommended Phase 2 Doses with Confidence

订阅时事通讯

快捷链接

解决方案

联系我们